Article
Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors.
The American journal of surgical pathology - 1 May 2022
Acosta Andres M, Al-Obaidy Khaleel I, Sholl Lynette M, Dickson Brendan C, Lindeman Neal I, Hirsch Michelle S, Collins Katrina, Fletcher Christopher D, Idrees Muhammad T
Abstract excerpt
In testicular germ cell tumors (TGCTs), components with nonspecific sarcomatous features that express keratins and glypican 3 are classified as sarcomatoid yolk sac tumor (SYST). SYST is most frequently seen in metastatic sites after chemotherapy. Like so-called "somatic-type" malignancies arising in TGCTs, SYST is markedly resistant to systemic therapy and has a more aggressive clinical course than conventional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
